R01 DA038446/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	1
2015	2
2016	5
2017	5
2018	9
2019	6
2020	1
2023	3
2024	1

1

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges.

Salinsky LM, Merritt CR, Zamora JC, Giacomini JL, Anastasio NC, Cunningham KA. Salinsky LM, et al. Front Pharmacol. 2023 Oct 11;14:1239159. doi: 10.3389/fphar.2023.1239159. eCollection 2023. Front Pharmacol. 2023. PMID: 37886127 Free PMC article. Review.

2

Drug Discovery Targeting Bromodomain-Containing Protein 4.

Liu Z, Wang P, Chen H, Wold EA, Tian B, Brasier AR, Zhou J. Liu Z, et al. J Med Chem. 2017 Jun 8;60(11):4533-4558. doi: 10.1021/acs.jmedchem.6b01761. Epub 2017 Mar 2. J Med Chem. 2017. PMID: 28195723 Free PMC article. Review.

3

GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends.

Zhou J, Wild C. Zhou J, et al. Curr Top Med Chem. 2019;19(16):1363-1364. doi: 10.2174/156802661916190828093500. Curr Top Med Chem. 2019. PMID: 31513505 Free PMC article.

4

Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

Ye N, Li B, Mao Q, Wold EA, Tian S, Allen JA, Zhou J. Ye N, et al. ACS Chem Neurosci. 2019 Jan 16;10(1):190-200. doi: 10.1021/acschemneuro.8b00572. Epub 2018 Dec 20. ACS Chem Neurosci. 2019. PMID: 30540906 Free PMC article. Review.

5

Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection.

Xu J, Wold EA, Ding Y, Shen Q, Zhou J. Xu J, et al. Molecules. 2018 Feb 22;23(2):474. doi: 10.3390/molecules23020474. Molecules. 2018. PMID: 29470395 Free PMC article. Review.

6

Discovery and development of natural product oridonin-inspired anticancer agents.

Ding Y, Ding C, Ye N, Liu Z, Wold EA, Chen H, Wild C, Shen Q, Zhou J. Ding Y, et al. Eur J Med Chem. 2016 Oct 21;122:102-117. doi: 10.1016/j.ejmech.2016.06.015. Epub 2016 Jun 13. Eur J Med Chem. 2016. PMID: 27344488 Free PMC article. Review.

7

Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022).

Ali S, Zhou J. Ali S, et al. Eur J Med Chem. 2023 Aug 5;256:115476. doi: 10.1016/j.ejmech.2023.115476. Epub 2023 May 13. Eur J Med Chem. 2023. PMID: 37207534 Free PMC article. Review.

8

Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Ye N, Chen H, Wold EA, Shi PY, Zhou J. Ye N, et al. ACS Infect Dis. 2016 Jun 10;2(6):382-92. doi: 10.1021/acsinfecdis.6b00041. Epub 2016 May 5. ACS Infect Dis. 2016. PMID: 27627626 Free PMC article. Review.

9

Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

Wold EA, Chen J, Cunningham KA, Zhou J. Wold EA, et al. J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28. J Med Chem. 2019. PMID: 30106578 Free PMC article. Review.

10

Direct Activation of Bax Protein for Cancer Therapy.

Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J. Liu Z, et al. Med Res Rev. 2016 Mar;36(2):313-41. doi: 10.1002/med.21379. Epub 2015 Sep 23. Med Res Rev. 2016. PMID: 26395559 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year